Jennifer B. Damico - 24 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role: SVP & Controller
Signature: Susan E. Grant, by power of atty., for Jennifer B. Damico
Issuer symbol: PFE
Transactions as of: 24 Feb 2023
Net transactions value: -$393,542
Form type: 4
Filing time: 17 Mar 2023, 16:53:29 UTC
Previous filing: 24 Feb 2023
Next filing: 28 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	$15,030	-360	-2.2%	$41.75	16,383	24 Feb 2023	Direct	F1
transaction	PFE	Common Stock	Sale	$396,678	-9,912	-52%	$40.02	9,003	15 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Phantom Stock Units SSP	Award	$18,166	+451	+2.2%	$40.28	21,176	15 Mar 2023	Common Stock	451		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2	Each unit represents one phantom share of common stock.
F3	These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.